YKL-40—A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients? by Julia S. Johansen, Nicolai A. Schultz

Get full text

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40 by Camilla Bjørnbak Holst, Camilla Bjørnbak Holst, Camilla Bjørnbak Holst, Camilla Bjørnbak Holst, Ib Jarle Christensen, Jane Skjøth-Rasmussen, Petra Hamerlik, Hans Skovgaard Poulsen, Julia Sidenius Johansen, Julia Sidenius Johansen, Julia Sidenius Johansen

Get full text

Circulating microRNAs as Prognostic and Predictive Biomarkers in Patients with Colorectal Cancer by Jakob Vasehus Schou, Julia Sidenius Johansen, Dorte Nielsen, Simona Rossi

Get full text

High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients with pancreatic ductal adenocarcinoma by Neel I. Nissen, Astrid Z. Johansen, Inna M. Chen, Christina Jensen, Emilie A. Madsen, Carsten P. Hansen, Jeppe Thorlacius-Ussing, Morten Karsdal, Julia S. Johansen, Julia S. Johansen, Julia S. Johansen, Hadi M. H. Diab, Lars N. Jørgensen, Lars N. Jørgensen, Nicholas Willumsen

Get full text

Associations between YKL-40 and markers of disease severity and death in patients with necrotizing soft-tissue infection by Morten Hedetoft, Marco Bo Hansen, Martin Bruun Madsen, Julia Sidenius Johansen, Ole Hyldegaard

Get full text

Antibody directed against human YKL-40 increases tumor volume in a human melanoma xenograft model in scid mice. by Johannes Salamon, Tatjana Hoffmann, Eva Elies, Kersten Peldschus, Julia S Johansen, Georg Lüers, Udo Schumacher, Daniel Wicklein

Get full text

Inflammatory Biomarker Score Identifies Patients with Six-Fold Increased Risk of One-Year Mortality after Pancreatic Cancer by Alisa D. Kjaergaard, Inna M. Chen, Astrid Z. Johansen, Børge G. Nordestgaard, Stig E. Bojesen, Julia S. Johansen

Get full text

Pretreatment Plasma IL-6 and YKL-40 and Overall Survival after Surgery for Metastatic Bone Disease of the Extremities by Michala Skovlund Sørensen, Thomas Colding-Rasmussen, Peter Frederik Horstmann, Klaus Hindsø, Christian Dehlendorff, Julia Sidenius Johansen, Michael Mørk Petersen

Get full text

CD6 and syntaxin binding protein 6 variants and response to tumor necrosis factor alpha inhibitors in Danish patients with rheumatoid arthritis. by Sophine B Krintel, Laurent Essioux, Assaf Wool, Julia S Johansen, Ehud Schreiber, Tomer Zekharya, Pinchas Akiva, Mikkel Ostergaard, Merete L Hetland

Get full text

Collagen Biomarkers Quantify Fibroblast Activity In Vitro and Predict Survival in Patients with Pancreatic Ductal Adenocarcinoma by Neel I. Nissen, Astrid Z. Johansen, Inna Chen, Julia S. Johansen, Rasmus S. Pedersen, Carsten P. Hansen, Morten A. Karsdal, Nicholas Willumsen

Get full text

Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with localized pancreatic ductal adenocarcinoma by Benjamin Emil Stubbe, Benjamin Emil Stubbe, Benjamin Emil Stubbe, Anders Christian Larsen, Anders Christian Larsen, Poul Henning Madsen, Poul Henning Madsen, Henrik Bygum Krarup, Henrik Bygum Krarup, Inge Søkilde Pedersen, Inge Søkilde Pedersen, Inge Søkilde Pedersen, Søren Lundbye-Christensen, Carsten Palnæs Hansen, Jane Preuss Hasselby, Astrid Zedlitz Johansen, Ole Thorlacius-Ussing, Ole Thorlacius-Ussing, Ole Thorlacius-Ussing, Julia Sidenius Johansen, Julia Sidenius Johansen, Julia Sidenius Johansen, Stine Dam Henriksen, Stine Dam Henriksen, Stine Dam Henriksen

Get full text

Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancer by Karen-Lise Garm Spindler, Christina Demuth, Boe Sandahl Sorensen, Julia S Johansen, Dorte Nielsen, Niels Pallisgaard, Estrid Hoegdall, Per Pfeiffer, Benny Vittrup Jensen

Get full text

A Randomized Placebo-Controlled Phase 2 Study of Gemcitabine and Capecitabine with or without T-ChOS as Adjuvant Therapy in Patients with Resected Pancreatic Cancer (CHIPAC) by Susann Theile, Julia Sidenius Johansen, Dorte Lisbet Nielsen, Benny Vittrup Jensen, Carsten Palnæs Hansen, Jane Preuss Hasselby, Sverrir Vídalín Eiríksson, Inna Markovna Chen

Get full text

Methods for the purification and detection of single nucleotide KRAS mutations on extrachromosomal circular DNA in human plasma by Lasse Bøllehuus Hansen, Sandra Fugl Jakobsen, Egija Zole, Julie Boertmann Noer, Li Tai Fang, Sefa Alizadeh, Julia Sidenius Johansen, Marghoob Mohiyuddin, Birgitte Regenberg

Get full text

miR-345 in metastatic colorectal cancer: a non-invasive biomarker for clinical outcome in non-KRAS mutant patients treated with 3rd line cetuximab and irinotecan. by Jakob V Schou, Simona Rossi, Benny V Jensen, Dorte L Nielsen, Per Pfeiffer, Estrid Høgdall, Mette Yilmaz, Sabine Tejpar, Mauro Delorenzi, Mogens Kruhøffer, Julia S Johansen

Get full text

Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: RESULTS from the NORDIC VII Study. by Line S Tarpgaard, Tormod K Guren, Bengt Glimelius, Ib J Christensen, Per Pfeiffer, Elin H Kure, Halfdan Sorbye, Tone Ikdahl, Mette Yilmaz, Julia S Johansen, Kjell Magne Tveit

Get full text

Combined plasma C‐reactive protein, interleukin 6 and YKL‐40 for detection of cancer and prognosis in patients with serious nonspecific symptoms and signs of cancer by Alex N. Videmark, Ib J. Christensen, Claus L. Feltoft, Mette Villadsen, Frederikke H. Borg, Barbara M. Jørgensen, Stig E. Bojesen, Caroline Kistorp, Randi Ugleholdt, Julia S. Johansen

Get full text

Transient Changes in Serum CEA, CA19-9, CRP, YKL-40, and IL-6 during Adjuvant Chemotherapy and Survival of Patients with Colorectal Cancer by Kaisa Lehtomäki, Eetu Heervä, Pirkko-Liisa Kellokumpu-Lehtinen, Harri Mustonen, Tapio Salminen, Heikki Joensuu, Kethe Hermunen, Mogens Karsbøl Boisen, Julia Sidenius Johansen, Caj Haglund, Pia Osterlund

Get full text

Levels of type XVII collagen (BP180) ectodomain are elevated in circulation from patients with multiple cancer types and is prognostic for patients with metastatic colorectal cance... by Marina Crespo-Bravo, Jeppe Thorlacius-Ussing, Neel I. Nissen, Rasmus S. Pedersen, Mogens K. Boisen, Maria Liljefors, Astrid Z. Johansen, Julia S. Johansen, Morten A. Karsdal, Nicholas Willumsen

Get full text

Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer by Troels D. Christensen, Kasper Madsen, Emil Maag, Ole Larsen, Lars Henrik Jensen, Carsten P. Hansen, Alice Markussen, Dan T. S. Høgdall, Inna M. Chen, Dorte Nielsen, Julia S. Johansen

Get full text